ArticleTheranostics2020
The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 40 citations in OpenAlex.
- A high density of T-cell lymphocytes and Tregs subset correlate to a worse survival in major salivary gland carcinomas.Scientific reports · 2026Article
- Exploration of potential biomarkers in salivary duct carcinoma based on bioinformatics analysis.Scientific reports · 2026Article
- Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier.Therapeutic advances in medical oncology · 2025Review
- Salivary gland macrophages in health and disease: heterogeneity, niche crosstalk, and therapeutic avenues.Frontiers in immunology · 2025Review
- The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma.Virchows Archiv : an international journal of pathology · 2024Article
- Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.Cancers · 2024Review
- Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer.Head and neck pathology · 2023Review
- Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR.Nucleic acids research · 2023Article
- Tumor-infiltrating lymphocytes and tumor-associated macrophages as potential predictors of lymph node metastases in major salivary gland cancers.Frontiers in medicine · 2023Article
- The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?International journal of molecular sciences · 2022Review
- Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.NPJ precision oncology · 2022Article
- The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy.BMC cancer · 2022Article
- Proteomics Study of Mesenchymal Stem Cell-Like Cells Obtained from Tumor Microenvironment of Patients with Malignant and Benign Salivary Gland Tumors.Cell journal · 2022Article
- Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer.Journal of clinical medicine · 2022Review
- Article
- An ancient, conserved gene regulatory network led to the rise of oral venom systems.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay.Biomedicines · 2021Article
- The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.Theranostics · 2021Article
- Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer.Molecular therapy. Nucleic acids · 2020Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 6 institutions in 3 countries.
Melissa AlameInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Emmanuel CornillotInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Valère CacheuxBiological Hematology Department, CHU Montpellier, Hôpital Saint Eloi, 34275 Montpellier, France.
Guillaume TosatoInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Marion FourBiopathology Department, CHU Montpellier, Hôpital Gui De Chauliac, 34000 Montpellier, France.
Laura De OliveiraBiopathology Department, CHU Montpellier, Hôpital Gui De Chauliac, 34000 Montpellier, France.
Stéphanie GofflotBiothèque, Université de Liège, 4000 Liège, Belgium.
Philippe DelvennePathology Department, CHU Liège, Université de Liège, 4000 Liège, Belgium.
Evgenia TurtoiInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Simon Cabello-AguilarInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Masahiko NishiyamaDepartment of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Gunma, Japan.
Andrei TurtoiInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Valérie Costes-MartineauUniversité de Montpellier, Faculté de Médecine, 2 rue école de Médecine, 34060 Montpellier, France.
Jacques ColingeInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, Parc Euromédecine, 208 rue des Apothicaires, 34298 Montpellier, France.
Université de Montpellier · FRHôpital Gui de Chauliac · FRInstitut de Radiobiologie Cellulaire et Moléculaire · FRUniversity of Liège · BEGunma University · JPInstitut de Recherche en Cancérologie de Montpellier · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, DuctalSalivary Gland NeoplasmsTumor MicroenvironmentAdultAgedAged, 80 and overBiomarkers, TumorCohort StudiesFemaleHumansMaleMiddle AgedProteomeSalivary DuctsTranscriptomeYoung AdultBiomarkers, TumorProteomeimmunotherapymolecular pathwayspersonalized medicinesalivary duct carcinomastroma
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.